Postural modifications and neuronal excitability changes induced by a short-term serotonin depletion during neonatal development in the rat.
Serotonin (5-HT) plays an important role both in the development and in the recovery of locomotion after spinalization in vertebrates. We investigated the contribution of the serotonergic system to the maturation of the lumbar motoneurons and networks in the neonatal rat. A 5-HT synthesis inhibitor, p-chlorophenylalanine (PCPA), was administered daily from the first postnatal day (P0) onward. This protocol depleted serotonin in the spinal cord within 3-4 d, as demonstrated by immunohistochemistry. PCPA-treated rats exhibited postural changes characterized by lesser flexion at the knee and ankle levels and lesser extension of the hip. Posture was asymmetric, suggesting possible deficits in the interlimb coordination. Intracellular recordings were made at P3-5 from motoneurons innervating different hindlimb muscles, using the in vitro brainstem-spinal cord-nerve-attached preparation. In PCPA-treated rats, the conduction velocity of motoneurons was increased, and their excitability was decreased (because of higher rehobase and input conductance) compared with sham animals. In accordance with postural observations, changes were more pronounced in hip extensor/knee flexor than in ankle extensor motoneurons. The maturation of repetitive firing properties was stopped by PCPA treatment, although PCPA, applied in vitro, had no effect on membrane properties. The spontaneous endogenously generated activity, which is a characteristic of immature networks, was increased in PCPA-treated rats, suggesting that developing lumbar networks are sensitive to 5-HT levels. Serotonin may play a critical role during development in regulating the balance between the excitability of motoneurons and that of interneurons. Interneuronal excitability is crucial for the activity-dependent development of spinal cord networks.
Pflieger
Jean-François
JF
Développement et Pathologie du Mouvement, Centre National de la Recherche Scientifique, F-13402 Marseille, Cedex 20, France.
Clarac
François
F
Vinay
Laurent
L
D000818:Animals; D000831:Animals, Newborn; D000843:Ankle Joint / Q000502:physiology; D001522:Behavior, Animal; D004791:Enzyme Inhibitors / Q000494:pharmacology; D010134:Fenclonine / Q000494:pharmacology; D006615:Hip / Q000502:physiology; D007700:Kinetics; D007717:Knee / Q000502:physiology; D008159:Lumbar Vertebrae; D009043:Motor Activity; D009046:Motor Neurons / Q000502:physiology*; D009431:Neural Conduction; D011187:Posture; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000502:physiology*; D013116:Spinal Cord / Q000033:anatomy & histology / Q000254:growth & development* / Q000502:physiology; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors
D004791:Enzyme Inhibitors; D012701:Serotonin; D014365:Tryptophan Hydroxylase; D010134:Fenclonine